Pricing & Access· May 24, 2026 · 11 min readSGLT2 inhibitor access landscape in 2026Compare SGLT2 access for Jardiance, Farxiga, Invokana, Steglatro, Brenzavvy, and Inpefa, including formularies, IRA prices, PA,...By Ran Chen#SGLT2 Inhibitor#Cardiovascular#Diabetes and Obesity
Pricing & Access· May 23, 2026 · 10 min readDOAC access landscape: Eliquis, Xarelto, Pradaxa, and Savaysa in 2026Cross-DOAC coverage guide for Eliquis, Xarelto, Pradaxa, and Savaysa. Formulary tiers, prior authorization, IRA negotiated prices,...By Ran Chen#DOAC#Coverage Access#Prior Authorization